Order Article Reprints

Narongkiatikhun P, Noppakun K, Chaiwarith R, Winichakoon P, Vongsanim S, Suteeka Y, Pongsuwan K, Kusirisin P, Wongsarikan N, Fanhchaksai K, et al. Correction: Narongkiatikhun et al. Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac^® and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study. Vaccines 2023, 11, 175. Vaccines. 2023; 11(10):1538. https://doi.org/10.3390/vaccines11101538

Narongkiatikhun, Phoom, Kajohnsak Noppakun, Romanee Chaiwarith, Poramed Winichakoon, Surachet Vongsanim, Yuttitham Suteeka, Karn Pongsuwan, Prit Kusirisin, Nuttanun Wongsarikan, Kanda Fanhchaksai, and et al. 2023. "Correction: Narongkiatikhun et al. Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac^® and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study. Vaccines 2023, 11, 175" Vaccines 11, no. 10: 1538. https://doi.org/10.3390/vaccines11101538

Narongkiatikhun, P., Noppakun, K., Chaiwarith, R., Winichakoon, P., Vongsanim, S., Suteeka, Y., Pongsuwan, K., Kusirisin, P., Wongsarikan, N., Fanhchaksai, K., Khamwan, C., Dankai, D., & Ophascharoensuk, V. (2023). Correction: Narongkiatikhun et al. Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac^® and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study. Vaccines 2023, 11, 175. Vaccines, 11(10), 1538. https://doi.org/10.3390/vaccines11101538